Sebastian Krawiec is Editor at Nutritional Outlook.
A subgroup analysis of the Aortic Valve Decalcification Trial (AVADEC study) observed that vitamin K2 MK-7 (720 µg/day) and D (25 µg/day) supplementation for two years helped slow the progression of coronary plaque development in individuals at high risk of developing coronary artery calcification
Results showed that the ingredient significantly decreased intraocular pressure, increased tear break-up time and volume, and decreased corneal inflammation, leading to the stabilization of the rats’ ocular surface.
Study finds that boosting omega-3 levels at early midlife may offer the best results for reducing the risk of age-related cognitive decline long-term.
Subjects showed improvements in hand grip strength tests as well as thinking, learning, memory, and concentration parameters of the psychological function domain of quality of life survey.
Results showed that at doses, ranging from 3 grams to 20 grams per day, the abundance of Bifidobacterium significantly increased.
The acquisition represents a market growth engine for Barentz and its principal suppliers because of Viachem’s dedicated market research and digitally enabled sales and marketing capabilities.
The patent demonstrates the synergistic effects of thymoquinone and omega-3 fatty acids for healthy inflammatory responses.
Vedic Lifesciences, a contract research organization based, has completed a randomized, controlled dose response study for Interpath Pty Ltd. on its patented ingredient called Epiitalis.
The International Society for the Study of Fatty Acids and Lipids (ISSFAL) has issued a statement acknowledging the relationship between omega-3 EPA and DHA blood levels and preterm birth risk.
According to the companies, the product is supported by a double-blind, placebo-controlled human study, pending publication, to support digestive health and enhance mood.
Coinciding with the White House Conference on Hunger, Nutrition, and Health, the U.S. Food and Drug Administration (FDA) has published a proposed rule which would change the criteria for foods to carry the “healthy” claim.
In a letter to the California State Assembly, Newsom explained that because “dietary supplements for weight loss are not considered drugs…this measure would require [the California Department of Public Health (CDPH)] to evaluate every individual weight loss and dietary supplement product for safety, which is beyond the scope of the department's capabilities.”
Mandatory product listing provision no longer attached to FDA user fee reauthorization legislation, based on newly introduced appropriations bill. Read for timeline of events that led to this point.
InVivo Biosciences and Thaena Inc. have announced results from recent research demonstrating measurably superior healthspan and lifespan benefits of ThaenaBiotic powder, a sterilized postbiotic mixture derived from healthy human stool.
When formulating beverages using fruit powders, dispersibility is a key consideration.
NPA submitted comments offering input to the White House Conference on Hunger, Nutrition, and Health on how to address nutrition and health integration.
Results showed that supplementation with the cocoa extract did not have a significant effect on global cognition, but relative to placebo, multivitamin mineral supplementation did provide significant benefit for global cognition.
The SQF program is administered by FMI, The Food Industry Association and benchmarked to the Global Food Safety Initiative (GFSI).
Results showed that, compared to placebo, subjects taking the microalgae supplement had fewer upper respiratory tract complaints, better overall well-being, as well as lower cortisol and superior microbiome indices.
Hofseth BioCare has announced a no-objection letter from FDA following an NDI notification for its ProGo bioactive peptides ingredient.
The extract helped improve lameness scores and inflammatory biomarkers in horses.
The ingredient is produced through a patented process by its supplier Extraordinary Extracts LLC, which is a division of American BioSciences.
The studies did not find a reduction in COVID-19 incidence after vitamin D supplementation, but a successful vaccination rollout may have impacted the results of the study.
The average time to achieve maximum levels in plasma following supplementation with the sustained release tablet was about 4.5 hours compared to the two to three hours seen in immediate-release formulations.
The study found that subjects with mild to moderate seborrhea of the scalp saw a significant 58.8.% reduction in erythema scores and a substantial 30% decrease in scaling scores after 28 days of using a 5% B’utyQuin Scalp Serum.
AIDP will be responsible for the sales and marketing efforts to promote the company’s GG-Gold and DuoQuinol ingredients from American River Nutrition.
Dubbed the VETA Trial (Vitamin D, K2 plus Empagliflozin combination in Type Two Diabetes Mellitus), the six-month prospective, randomized, controlled, open-label, multicenter trial will be conducted in collaboration with the University of Health Sciences Lahore (Pakistan) and the Pakistan Society of Internal Medicine.
Nutiani will offer customers end-to-end solutions through a combination of wellbeing nutrition products, concepts, and services that leverage the Co-op’s intellectual property and investments in research.
Products like tofu and tempeh may not get the same press as flashier meat alternatives, but they still play a prominent role in the plant-based diet.
The company operates according to cGMPs under 21 CFR part 111 and part 117, with an FDA-compliant fulfillment facility in Reno, NV.
